Abstract
During the past few decades, the survival of systemic lupus erythematosus (SLE) patients has steadily improved, so much so that it has become a minor issue with a mortality rate of approximately 1-2% per annum [2, 11]. The main problem today for lupus patients concerns their quality of life and the risk of loss of kidney function. Indeed, too many patients still lose this function (9% after 5 years of disease, 17% after 10 years) [2]. The aim of today’s management of SLE is thus centred on allowing patients a good quality of life in both professional and personal terms, including the possibility of having children.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Beris P, Burger A, Favre L, Riondel A, Miescher PA (1986) Adrenocortical responsiveness after discontinuous corticosteroid therapy. Klin Wochenschr 64: 70
Esdaile JM (1994) Prognosis in systemic lupus erythematosus. Springer Semin Immunopathol 16: 337
Favre H (1973) Détermination des fonctions rénales par la technique de l’injection unique. Analyse statistique de modéle bicompartimental proposé par Sapirstein. J Urol Nephrol 79: 1007
Feutren G, Querin S, Tron F, Noel LH, Chatenoud L, Lesavre P, Bach JF (1986) The effects of cyclosporine in patients with systemic lupus. Transplant Proc 18: 643 factor: parameters of production and a quantitative microassay for activity. J Immunol 120: 2027
Horwitz DA, Jacob CO (1994) The role of cytokines in the pathogenesis of systemic lupus erythematosus. Springer Semin Immunopathol 16: 181
Huang YP, Miescher PA, Zubler RH (1986) The interleukin 2 secretion defect in vitro in systemic lupus erythematosus is reversible in rested cultured T cells. J Immunol 137: 3515
Huang YP, Perrin LH, Miescher PA, Zubler RH (1988) Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus. J Immunol 141: 827
Huang YP, Pechere JC, Michel M, Gauthey L, Loreto M, Curran JA, Michel JP (1992) In vivo T cell activation, in vitro defective IL-2 secretion, and response to influenza vaccination in elderly women. J Immunol 148: 715
Izui S, Lambert PH, Miescher PA (1976) Deterruination of anti-DNA antibodies by a modified 125I-labelled DNA-binding test. Elimination of non-specific binding of DNA to non-immunoglobulin basic proteins by using an anionic detergent. Clin Exp Immunol 26: 423
McLaughlin J, Gladman DD, Urowitz MB, Bombardier C, Farewell VT, Cole E (1991) Kidney biopsy in systemic lupus erythematosus. II. Survival analyses according to biopsy results. Arthritis Rheum 34: 1268
Miescher PA, Favre H, Chatelanat F, Mihatsch MJ (1987) Combined steroid-cyclosporin treatment of chronic autoimmune diseases. Klin Wochenschr 65: 727
Miescher PA, Huang YP, Zubler RH (1988) New approaches to the treatment of RA. Springer Semin Immunopathol 10: 251
Perrin LH, Lambert PH, Nydegger U, Miescher PA (1973) Quantitation of C3PA and other complement components in diseases associated with a low C3 level. Clin Immunol Immunopathol 2: 16
Rubin LA, Kurman CC, Fritz ME, Biddison WE, Boutin B, Yarchoan R, Nelson DL (1985) Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 135: 3172
Steinberg AD, Steinberg S (1991) Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only. Arthritis Rheum 34: 945
Waldmann TA (1993) The IL-2/IL-2 receptor system: a target for rational immune intervention. Immunol Today 14: 264
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Miescher, P.A., Favre, H., Lemoine, R., Huang, YP. (1995). Drug combination therapy of systemic lupus erythematosus. In: Miescher, P.A. (eds) Systemic Lupus Erythematosus. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79622-7_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-79622-7_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79624-1
Online ISBN: 978-3-642-79622-7
eBook Packages: Springer Book Archive